Dr. Behbehani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-7677Fax+1 614-293-5614
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2008 - 2011
- University of ChicagoResidency, Internal Medicine, 2005 - 2008
- University of Cincinnati College of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2008 - Present
- OH State Medical License 2015 - 2025
Clinical Trials
- Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction Start of enrollment: 2021 Jan 29
Publications & Presentations
PubMed
- Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors.Emily Schwarz, Brooke Benner, Robert Wesolowski, Dionisia Quiroga, Logan Good
JCI Insight. 2024-11-08 - 2 citationsEfficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803andin NB xenografts.Yaya Chu, Gaurav Nayyar, Meijuan Tian, Dean A Lee, Mehmet F Ozkaynak
Molecular Therapy. Oncology. 2024-06-20 - BRAF V600E in a preclinical model of pleomorphic Xanthoastrocytoma: Analysis of the tumor microenvironment and immune cell infiltration dynamics.Alessandro Canella, Matthew Nazzaro, Mykyta Artomov, Lakshmi Prakruthi Rao Venkata, Diana Thomas
Molecular Therapy. Oncology. 2024-06-20
Books/Book Chapters
Abstracts/Posters
- CircPCMTD1: A Protein-Coding Circular RNA That Regulates DNA Synthesis in Leukemic MyeloblastsGregory K. Behbehani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- NPM1 mutations Using Deep Amplicon Sequencing and Broad Next Generation Sequencing at the Time of Complete Remission Is Informative to Predicting Risk of Relapse Follo...Gregory K. Behbehani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803...Gregory K. Behbehani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: